Pelago Bioscience AB published a new article about CETSA in action for degrader research.
Published
Signal category
Research & Knowledge
Quote
“Timing is everything. Read about another fantastic example of #CETSA in action for #degrader research.”
— Brian W. J.|Pelago Bioscience AB team
Company
Pelago Bioscience AB
Pelago Bioscience
- Industry
- Biotechnology Research
- Location
- Solna, SE
- Company size
- 65 employees
At Pelago Bioscience, we’re here to help you make faster, better-informed decisions in drug discovery. In 2010, our founders began to develop our proprietary CETSA® (Cellular Thermal Shift Assay) technology, publishing a seminal research paper in Science 2013. Since then, Pelago Bioscience has become the leading CRO providing actionable, biologically relevant insights at the pre-clinical stage.Unlike traditional methods, CETSA gives you a reliable picture of drug-target interactions, ensuring that what you see in cells translates to patients. Our services rest on four pillars: • Certainty in Biological Relevance: CETSA’s physiological approach helps minimize late-stage risks. • Fast & Early Confidence: We deliver actionable insights in just 10 days-10 weeks (service dependent), eliminating unnecessary complexities so you can make decisions faster. • Insights & Progress: Our data supports compound prioritization and predicts future research steps, reducing project costs. • Extended Team Support: We work as your dedicated partner, designing fit-for-purpose studies that align with your goals. With Pelago Bioscience, you gain more than just data; you gain a trusted partner in your discovery journey.
Founded 2013